# Patrick Rossignol

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patrick-rossignol-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,829 |
| Field | Heart Failure Treatment and Management |
| h-index | 54 |
| i10-index | 167 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5081791142 |
| ORCID iD | 0000-0003-4470-7932 |
| Works | 309 |

## Researcher papers

- [Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/potassium-homeostasis-and-management-of-dyskalemia-in-kidney-diseases/)
- [Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction](https://scholariq.org/papers/epinephrine-versus-norepinephrine-for-cardiogenic-shock-after-acute-myocardial/)
- [The systemic nature of CKD](https://scholariq.org/papers/the-systemic-nature-of-ckd/)
- [Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure](https://scholariq.org/papers/epidemiology-contributors-to-and-clinical-trials-of-mortality-risk-in-chronic/)
- [Heart failure drug treatment](https://scholariq.org/papers/heart-failure-drug-treatment/)
- [Cardiorenal Syndrome Revisited](https://scholariq.org/papers/cardiorenal-syndrome-revisited/)
- [Involvement of the Mural Thrombus as a Site of Protease Release and Activation in Human Aortic Aneurysms](https://scholariq.org/papers/involvement-of-the-mural-thrombus-as-a-site-of-protease-release-and-activation/)
- [Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents](https://scholariq.org/papers/treatment-with-multiple-blood-pressure-medications-achieved-blood-pressure-and/)
- [Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure](https://scholariq.org/papers/influence-of-baseline-and-worsening-renal-function-on-efficacy-of-spironolactone/)
- [Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology](https://scholariq.org/papers/heart-failure-and-diabetes-metabolic-alterations-and-therapeutic-interventions-a/)
- [Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( <b>AMBER</b> ): Results in the Pre-Specified Subgroup with Heart Failure](https://scholariq.org/papers/patiromer-versus-placebo-to-enable-spironolactone-use-in-patients-with-resistant-2/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.